Moderna: Interim Data Show 94.5% Efficacy for Its COVID-19 Vaccine ...Middle East

News by : (Medscape) -
In a highly anticipated announcement, Moderna releases interim efficacy and safety data from the phase 3 COVE study of its COVID-19 vaccine. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Moderna: Interim Data Show 94.5% Efficacy for Its COVID-19 Vaccine )

Also on site :

Most Viewed News
جديد الاخبار